BNP/CALL/ELI LILLY & CO/700/0.1/20.12.24 | Market Closed - Boerse Frankfurt Warrants 20:50:36 05/07/2024 BST | ||
| 22.37 EUR | +4.73% |
|
| Current month | +1.22% | ||
| 1 month | +40.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 22.45 | +5.10% |
| 04/07/24 | 21.36 | +0.99% |
| 03/07/24 | 21.15 | -4.04% |
| 02/07/24 | 22.04 | -1.39% |
| 01/07/24 | 22.35 | +0.77% |
Real-time Boerse Frankfurt Warrants
Last update July 05, 2024 at 08:50 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PZ1XP3 |
| ISIN | DE000PZ1XP37 |
| Date issued | 30/11/2023 |
| Strike | 700 $ |
| Maturity | 20/12/2024 (167 Days) |
| Parity | 10 : 1 |
| Emission price | 4.49 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 22.77 € |
|---|---|
| Lowest since issue | 3.5 € |
| Delta | 0.89x |
| Omega | 3.365 |
| Premium | 3.05x |
| Gearing | 3.77x |
| Moneyness | 1.307 |
| Difference Strike | -214.6 $ |
| Difference Strike % | -30.65% |
| Spread | 0.02 € |
| Spread % | 0.09% |
| Theoretical value | 22.35 |
| Implied Volatility | 37.80 % |
| Total Loss Probability | 15.85 % |
| Intrinsic value | 19.79 |
| Present value | 2.557 |
| Break even | 942.29 € |
| Theta | -0.13x |
| Vega | 0.1x |
| Rho | 0.24x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6
USD
Average target price
870.3
USD
Spread / Average Target
-4.84%
- Stock Market
- Warrants
- Warrant
